Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Leukemia, Prolymphocytic, B-Cell × Blood Component Removal × Clear all

Sponsor

Conditions

Multiple Myeloma 5 Lymphoma, Non-Hodgkin 3 Lymphoma 3 Melanoma 2 Leukemia 2 Immunoglobulin Light-chain Amyloidosis 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Philadelphia Chromosome 1 Neoplasms, Plasma Cell 1 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Lymphoma, B-Cell 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, B-Cell 1 Hodgkin Disease 1 Burkitt Lymphoma 1 Breast Neoplasms 1

Interventions

fludarabine phosphate 2 Whole-Body Irradiation 2 Mycophenolic Acid 2 obinutuzumab 1 letermovir 1 carmustine, poliferprosan 20 drug combination 1 Tacrolimus 1 Stem Cell Transplantation 1 Peripheral Blood Stem Cell Transplantation 1 Melphalan 1 Hematopoietic Stem Cell Transplantation 1 Etoposide 1 Cytarabine 1 Cyclosporins 1 Cyclosporine 1 Cyclophosphamide 1 Carmustine 1 6-(1H-indazol-6-yl)-N-(4-morpholinophenyl)imidazo(1,2-a)pyrazin-8-amine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡